Factors influencing the use of direct oral anticoagulants among patients with chronic chagas cardiomyopathy. [PDF]
Gómez-Ochoa SA +6 more
europepmc +1 more source
[Determinants of bleeding risk in anticoagulated patients in primary care: A retrospective observational study]. [PDF]
Ciorba FR +2 more
europepmc +1 more source
[Previous treatment with oral anticoagulant is not a protective factor for thromboembolic events in patients with COVID-19]. [PDF]
Vallès Fernández R +3 more
europepmc +1 more source
Nuevos anticoagulantes orales: ¿Qué Dicen Las Guías?
Background: Traditional oral anticoagulants, primarily warfarin, have occupied a central place in the prevention and treatment of thromboembolic diseases since their development in the 1940s.
Sossa Pinzón, Luis Alfredo +6 more
core
[Diagnostic and treatment protocol for vascular complications of COVID-19]. [PDF]
Sánchez FG +2 more
europepmc +1 more source
[The family doctor and the barriers to prescribing the new oral anticoagulants: Heterogeneity, inequality and confusion. Statement of the Spanish Primary Care and Family Medicine Societies]. [PDF]
Lobos Bejarano JM +2 more
europepmc +1 more source
[Clinical and prognostic profile evolution of patients discharged from hospital due to heart failure in the first two decades of the 21st century. The INCA-Ex Registry]. [PDF]
Fernández-Bergés D +9 more
europepmc +1 more source
[Pharmacological interactions in patients treated with oral anticoagulants in a rural health area]. [PDF]
Sánchez-Garrido Escudero R +4 more
europepmc +1 more source
[Quality of life of patients treated with oral anticoagulants]. [PDF]
Yanes Baonza M +3 more
europepmc +1 more source
Mantenimiento de tratamientos crónicos en pacientes afectados de COVID-19. [PDF]
Sánchez JMR +2 more
europepmc +1 more source

